A novel ammonium salt of Bosentan of formula (VIII) Formula (VIII) has been disclosed. The salt may be either crystalline or amorphous or mixture of Crystalline and amorphous form. A novel single pot process for the preparations of ammonium salt of Bosentan has been disclosed. The process comprises reacting the 4,6-dichIoro-5-(2-methoxyphenoxy)-2,2"-bipyrimidine with 4-tert-butylbenzenesulfonamide in the presence of solvent and a base adding ethylene glycol to the reaction mass and isolating the ammonium salt of Bosentan. The ammonium salt of Bosentan is converted into Bosentan and further into Bosentan Monohydrate which are substantially free from dimer impurity and 6-hydroxy impurity.
